This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Before getting a travel rewards card, consider various factors like fees and rewards structure. Make sure it aligns with your spending habits.
18,240 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
A big-name hedge fund recently disclosed a fresh stake in a leading utility company, adding roughly 1.9 million share...
Oil breaks through $119 as geopolitical risk spikes. This article explains why this nuclear energy stock may stand ou...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
When a member of a royal family steps into the public eye after a major news cycle, personal finances can feel the pr...
Could Starbucks be hiding dividend upside under a modest price tag? This guide breaks down how to judge whether starb...
Rivian vs. Lucid pits two high-profile EV startups against each other. This guide breaks down business models, capita...
SCHB and VTV offer low-cost ways to invest in U.S. stocks, but they serve different purposes. One captures the broad ...
XRP is navigating a critical moment as Ripple deploys AI-driven security testing across the XRP Ledger. The move aims...
A top Interface executive dumped stock in a move worth hundreds of thousands. Is this a signal about the business or ...
In a dramatic Q1, a bold Bitcoin-focused strategy posts a $12.5 billion loss. This article explains what happened, wh...